Eminence Capital’s Thermo Fisher Scientific TMO Stock Holding History

Eminence Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-475,338	Closed	-$138M	–	67
2019 Q3	$138M	Buy	475,338 +117,776	+33%	+$33.7M	1.67%	25
2019 Q2	$105M	Sell	357,562 -226,265	-39%	-$62.3M	1.39%	30
2019 Q1	$160M	Buy	583,827 +12,532	+2%	+$3.12M	2.38%	18
2018 Q4	$128M	Buy	+571,295	New	+$134M	2.49%	20
2016 Q1	–	Sell	-699,225	Closed	-$99.2M	–	55
2015 Q4	$99.2M	Buy	699,225 +10,337	+2%	+$1.38M	1.23%	33
2015 Q3	$84.2M	Buy	+688,888	New	+$89.7M	1.29%	41

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Eminence Capital's TMO Position: Q4 2019 in Review

Eminence Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2019, closing a stake of 475,338 shares — an estimated $138M sold.

Eminence Capital first reported a position in TMO in Q3 2015 and held it in 6 quarters. The position peaked at $160M in Q1 2019. 1,678 funds tracked by Wall St. Rank hold TMO as of Q4 2019.

Eminence Capital reported no remaining Thermo Fisher Scientific position as of Q4 2019 after selling out during the quarter.
Eminence Capital sold 475,338 Thermo Fisher Scientific shares in Q4 2019, an estimated $138M.
Eminence Capital first reported a position in Thermo Fisher Scientific in Q3 2015 and held it in 6 quarters.
Eminence Capital's Thermo Fisher Scientific position peaked at $160M in Q1 2019.
1,678 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2019.

Based on Eminence Capital's 13F filing for Q4 2019, filed 14 Feb 2020.